Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Notebook
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
FDA Bans Common Food Dye 'Red No. 3'
FDA Bans Red Dye No. 3 From Food, Beverages and Ingested Drugs, Citing Link to Cancer in Lab Rats
After decades of debate, the Food and Drug Administration (FDA) has announced a ban on Red Dye No. 3, a synthetic food coloring that’s been linked to cancer in male lab rats. The decision comes after a petition filed in 2022 by advocacy groups,
FDA moves to ban Red 3, citing concern over cancer in some animals
FDA officials have telegraphed the decision for months. While the agency has long said that it did not think evidence of Red 3 causing cancer applied to humans, officials said their hand was forced by a law requiring the agency to pull additives that are cancerous in animals.
FDA bans Red Dye 3 over cancer concerns
The controversial artificial food dye Red 3 was banned Wednesday by the Food and Drug Administration nearly 35 years after the dye was removed from cosmetics due to cancer concerns. Dr. Eric Ascher, family medicine physician at New York City's Northwell Lenox Hill Hospital,
colorectal cancer, Amgen
US FDA approves Amgen's colorectal cancer therapy
The U.S. Food and Drug Administration approved Amgen's combination therapy on Thursday to treat colorectal cancer in patients with a specific gene mutation.
FDA approves therapies for colorectal cancer, mantle cell lymphoma
The FDA approved two oncology regimens on Jan. 16.One is for a subset of patients with colorectal cancer and the other for treatment of patients with mantle cell lymphoma.
Amgen's Lumakras+Vectibix Combo Gets FDA Approval For Metastatic Colorectal Cancer Treatment
Friday announced that the U.S. Food and Drug Administration has approved its Lumakras plus Vectibix combination
3h
on MSN
US FDA approves AstraZeneca's drug for breast cancer
The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of ...
Cape and Islands NPR
42m
Zyn nicotine pouches can be marketed in the U.S., the FDA says. What does this mean?
The FDA said "an extensive scientific review" found the products were found to pose lower risks of cancer and other serious ...
2h
AstraZeneca Gets FDA Approval for Metastatic Breast Cancer Treatment Datroway
AstraZeneca said the U.S. Food and Drug Administration approved Datroway, a treatment for metastatic breast cancer developed in combination with Daiichi Sankyo.
phillyvoice.com
3h
The FDA wants to limit nicotine in cigarettes — a move that could save millions of lives
Temple pulmonologist Dr. Jamie Garfield says the proposed regulation is an effective harm reduction strategy, but suggests it ...
3d
on MSN
To combat chronic diseases, FDA proposes putting nutrition labels on front of packages
The proposed "Nutrition info box" would show customers whether products have low, medium or high levels of saturated fat, sodium and added sugars.
4d
AbbVie secures option to license Simcere's blood cancer drug candidate
Simcere Pharmaceutical said on Monday its unit had granted U.S. drugmaker AbbVie the option to license its new blood cancer ...
4d
Top 5 Cancer Pharma Stocks With Strong Risk/Reward In 2025
The cancer therapeutics market is set to exceed $400 billion. Read why five pharmaceutical companies offer attractive ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback